PharmaBoardroom Releases 'Healthcare and Life Sciences Review Special Report: Central & Eastern Europe'

Wednesday, April 5, 2017 Drug News
Email Print This Page Comment
Font : A-A+

LONDON, April 5, 2017 /PRNewswire/ --

PharmaBoardroom today releases its new 34-page Healthcare & Life Sciences

Review Special Report: Central & Eastern Europe 2017.

This special report offers companies, investors, policymakers, and stakeholders crucial insight into Central and Eastern Europe (CEE): a dynamic

region, located strategically at the crossroads between Western Europe and the East, that has largely recovered from the global economic crisis of 2008 and is forging a formidable reputation for itself as a high-expertise, low-cost destination for the healthcare and life science industries.

The report features in-depth and exclusive facts and figures on the region's macroeconomy, healthcare systems, and pharmaceutical industries, as well as in-depth exclusive interviews with leading figures from public institutions and private companies, as well as comprehensive articles offering a snapshot of what the Czech Republic, Slovakia, Romania, and Hungary have to offer respectively to global investors.

Featured countries 

Czech Republic 

  • Czechia: A Regional Role Model
  • Zentiva: A National Icon

Slovakia 

  • Not to be Underestimated!
  • Why Invest in Slovakia?

Romania 

  • Raed Arafat: A Man on a Mission
  • Contract Manufacturing: Romania's Secret Weapon

Hungary 

  • An Innovation Nation
  • Hurdling Hardship

Quotes 

"In the Czech Republic we have the right balance between sophisticated regulations in terms of transparency and quality, while being one of the fastest countries in the CEE region to grant market access" - Jakub Dvoracek, AIFP

"In the macroeconomic perspective, Slovakia today displays all the characteristics of a modern, successful, liberal market economy" - Vladimir Masar, Deloitte

"[Romania's] local producers offer competitive and more affordable prices compared to the rest of the EU and yet our quality standards are equivalent to and, in some cases, even superior due to the modernity of our factories." - Radu Cazacincu, Magistra C&C

"Hungary is no longer just a low-wage target country for investment, where assembly and manufacturing are carried out" - Peter Szijjarto, Minister of Foreign Affairs & Trade

Click here to register and download the report.

SOURCE PharmaBoardroom



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook